PRIME MEMBER EXCLUSIVE | 3 Months Free Trial

Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.

Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Listen for free

View show details

Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.

No reviews yet